Sept. 2, 2011 | Vol. 3 No. 35
The FDA is halting imports from Indian pharma giant Dr. Reddy’s Mexico facility after issuing the company a June warning letter for cGMP violations.
Winston Salem, N.C.-based Cook Endoscopy recently received an FDA Form 483 for failing to determine if recalled devices are permanently removed from the market.
Beckman Coulter diagnostic analyzers, reagents, calibrators and controls violate current good manufacturing practice requirements, the FDA says.
India has cancelled the import license granted to a Chinese pharma company after it refused to allow an Indian team to inspect the facility, Health Minister Ghulam Nabi Azad said.
Another 128 employees at a Buffalo pharmaceutical firm will lose their jobs in late November and late December as the company prepares to shut down.
Gov. Bob McDonnell says Pfizer is selling its manufacturing plant in Henrico County to Fareva.
Promega breaks ground for a current good manufacturing practice facility dedicated to accommodate business growth and its customers who need FDA-regulated molecular biology products.
It’s always a fascinating thought that your unassuming generic pain-killers are actually produced by some of the most technologically advanced laboratories on earth.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.